Importantly, in support of our hypothesis, analysis of FGFR1 and FGFR4 protein expression of the patient tumor showed co-overexpression of FGFR1 (IHC score 120) and FGFR4 (IHC score 60) (Figure 1G). This evidence concerns the gene FGFR4 and neoplasm.